Knvul Sheikh addresses new research which includes identified a achievable blood marker of sudden toddler Loss of life syndrome (SIDS).Other researchers including David Dowling and Dr. Ofer Levy, each Ovax co-founders, are using adjuvants that haven’t been tested in individuals but look to efficiently enhance the immune reaction to vaccines targe